Cationic lipids and methods of use

Details Cationic lipids and methods of use Cationic lipids and methods of use

2005-06-07

2010-06-29

Kelly, Robert M (Department: 1633)

Organic compounds -- part of the class 532-570 series

Organic compounds

Fatty compounds having an acid moiety which contains the...

C424S009510, C424S450000, C554S105000, C554S108000, C554S110000, C554S127000, C514S04400A

Reexamination Certificate

active

07745651

ABSTRACT:
The present invention provides compositions comprising cationic lipids, liposomes and nucleic acid-lipid particles comprising the cationic lipids, and methods of using such compositions, liposomes, and nucleic acid-lipid particles.

REFERENCES:
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4438052 (1984-03-01), Weder et al.
patent: 4515736 (1985-05-01), Deamer
patent: 4598051 (1986-07-01), Papahadjopoulos et al.
patent: 4897355 (1990-01-01), Eppstein et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5171678 (1992-12-01), Behr et al.
patent: 5208036 (1993-05-01), Eppstein et al.
patent: 5225212 (1993-07-01), Martin et al.
patent: 5264618 (1993-11-01), Felgner et al.
patent: 5279833 (1994-01-01), Rose
patent: 5283185 (1994-02-01), Epand et al.
patent: 5320906 (1994-06-01), Eley et al.
patent: 5545412 (1996-08-01), Eppstein et al.
patent: 5578475 (1996-11-01), Jessee et al.
patent: 5641662 (1997-06-01), Debs et al.
patent: 5656743 (1997-08-01), Busch et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5705385 (1998-01-01), Bally et al.
patent: 5820873 (1998-10-01), Choi et al.
patent: 5976567 (1999-11-01), Wheeler et al.
patent: 5981501 (1999-11-01), Wheeler et al.
patent: 6534484 (2003-03-01), Wheeler et al.
patent: 6586410 (2003-07-01), Wheeler et al.
patent: 6649780 (2003-11-01), Eibl et al.
patent: 6815432 (2004-11-01), Wheeler et al.
patent: 6858224 (2005-02-01), Wheeler et al.
patent: 2003/0077829 (2003-04-01), MacLachlan
patent: 2003/0125263 (2003-07-01), Gold et al.
patent: 2003/0143732 (2003-07-01), Fosnaugh et al.
patent: 2004/0063654 (2004-04-01), Davis et al.
patent: 2004/0142892 (2004-07-01), Finn et al.
patent: 2004/0253723 (2004-12-01), Tachas et al.
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 2006/0105976 (2006-05-01), Soutschek et al.
patent: WO 91/16024 (1991-10-01), None
patent: WO 93/05162 (1993-03-01), None
patent: WO 93/12240 (1993-06-01), None
patent: WO 93/12756 (1993-07-01), None
patent: WO 93/24640 (1993-12-01), None
patent: WO 93/25673 (1993-12-01), None
patent: WO 95/02698 (1995-01-01), None
patent: WO 95/18863 (1995-07-01), None
patent: WO 95/35301 (1995-12-01), None
patent: WO 96/02655 (1996-02-01), None
patent: WO 96/10390 (1996-04-01), None
patent: WO 96/41873 (1996-12-01), None
patent: WO 01/05374 (2001-01-01), None
patent: WO 02/34236 (2002-05-01), None
patent: WO 02/087541 (2002-11-01), None
patent: WO 03/097805 (2003-11-01), None
patent: WO 2004/065546 (2004-08-01), None
patent: WO 2004/110499 (2004-12-01), None
patent: WO 2005/007196 (2005-01-01), None
patent: WO 2005/026372 (2005-03-01), None
patent: WO 2005/120152 (2005-12-01), None
Arpicco et al., 1999, Proceed. Int'l Symp. Control. Rel. Bioact. Mater. 26:7759-760 (+face page).
Ballas, N. et al., “Liposomes bearing a quartemary ammonium detergent as an efficient vehicle for functional transfer of TMV-RNA into plant protoplasts,”Biochim. Biophys. Acta,1998, pp. 8-18, vol. 939.
Barinaga, M., “Step Taken Toward Improved Vectors for Gene Transfer,”Science,1994, p. 1326, vol. 266.
Behr, J-P., “Synthetic Gene-Transfer Vectors,”Acc. Chem. Res.1993, pp. 274-278, vol. 26.
Brigham, K. et al., “Rapid Communication: In vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene Using a Liposome Vehicle,”Am. J. Med. Sci.,1989, pp. 278-281, vol. 298.
Cortesi, R., et al.. “Effect of cationic liposome composition on in vitro cytotoxicity and protective effect on carried DNA,”International Journal of Pharmaceutics,1996, pp. 69-78, vol. 139.
Crystal, R., “Transfer of Genes to Humans: Early Lessons and Obstacles to Success,”Science,1995, pp. 404-410, vol. 270.
Culver K.,, “The First Human Gene Therapy Experiment,”Gene Therapy: A Handbook for Physicians,1994, pp. 33-40.
Duzgunes, N., “Membrane Fusion,”Subcellular Biochemistry,1985, pp. 195-286, vol. 11.
Dwarki, V.J., et al., “Cationic Liposime-Mediated RNA Transfection.”Methods in Enzymology,1993, pp. 644-654, vol. 217.
Enoch, H. et al., “Formation and properties of 1000-Å-diameter, single-bilayer phospholipid vesicles,”Proc. Natl. Acad. Sci. USA,1979, pp. 145-149, vol. 76, No. 1.
Felgner, P. et al., “Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure,”Proc. Natl. Acad. Sci. USA,1987, pp. 7413-7417, vol. 84.
Felgner, J.H., et al., “Enhanced Gene Delivery and Mechanism Studies with a Novel Series of Cationic Lipid Formulations,”The Journal of Biological Chemistry,Jan. 1994, pp. 2550-2561, vol. 269, No. 4.
Felgner, J., et al., “Cationic Lipid-Mediated Transfection in Mammalian Cells: “Lipofection”,”J. Tiss. Cult. Meth.,1993, pp. 63-68, vol. 15.
Felgner, P.L., et al., “Cationic Liposome Mediated Transfection,”Proc. West. Pharmacol. Soc.,1989, pp. 115-121, vol. 32.
Gao, X. et al., “A Novel Cationic Liposome Reagent for Efficient Transfection of Mammalian Cells,”Biochem. Biophys. Res. Comm.,1991, pp. 280-285, vol. 179.
Gershon, H. et al., “Mode of Formation and Structural Feature of DNA-Cationic Liposome Complexes Used for Transfection,”Biochemistry,1993, pp. 7413-7151, vol. 32.
Guy-Caffey, J., et al., “Novel Polyaminolipids Enhance the Cellular Uptake of Oligonucleotides,”The Journal of Biological Chemistry,Dec. 1995, pp. 31391-31396, vol. 270, No. 52.
Hawley-Nelson, et al., “LipofectAmine™ Reagent: A New, Higher Efficiency Polycationic Liposome Transfection Reagent,”Focus,1993, p. 73-80, vol. 15, No. 3.
Hyde, S., et al., “Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy,”Nature,1993, pp. 250-256, vol. 362.
Jiang, Lei et al.; “Comparison of protein precipitation methods for sample preparation prior to proteomic analysis”; 2004,Journal of Chromatography,vol. 1023, No. 2, pp. 317-320.
Juliano R., and Stamp, D., “The Effect of Particle Size and Charge on the Clearance Rates of Liposomes and Liposome Encapsulated Drugs,”Biochem. Biophys. Res. Commun.,1975, pp. 651-658, vol. 63.
Legendre, J.Y. and Szoka, F., “Delivery of Plasmid DNA into Mammalian Cell Lines Using pH-Sensitive Liposomes: Comparison with Cationic Liposomes,”Pharm. Res.,1992, pp. 1235-1242, vol. 9, No. 10.
Leventis, R., et al.,, “Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles,”Biochem. Blophys. Acta,1990, p. 124, vol. 1023.
Marshall, E., “Gene Therapy's Growing Pains,”Science,1995, pp. 1050-1055. vol. 269.
Orkin, et al.,NIH Report, Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy,1995.
Paul, Cynthia P. et al.; “Effective expression of small Interfering RNA in human cells”; 2002,Nature Biotechnology,vol. 20, pp. 505-508.
Puyal, C., et al., “A new cationic liposome encapsulating genetic material: A potential delivery system for polynucleotides,”Eur. J. Biochem.,1995, pp. 697-703, vol. 228.
Spagnou, Sebastien et al.; “Lipidic Carriers of siRNA: Differences in the Formulation, Cellular Uptake, and Delivery with Plasmid DNA”; 2004,Biochemistry,vol. 43, pp. 13348-13356.
Stamatatos, L, et al., “Interactions of Cationic Lipid Vesicles with Negatively Charged Phospholipid Vesicles and Biological Membranes,”Biochemistry,1988, pp. 3917-3925, vol. 27.
Szoka, F. et al., “Comparative Properties and Methods of Preparation of Lipid Vesicles (Liposomes),”Ann. Rev. Biophys. Bioeng.,1980, pp. 467-508, vol. 9.
Szoka, F. et al., “Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation,”Proc. Natl. Acad. Sci. USA,1978, pp. 4194-4198, vol. 75, No. 9.
Van Der Woude, I., et al., “Parameters influencing the Introduction of plasmid DNA into cells by the use of synthetic amphiphiles as a carrier system,&#

Affiliated with

Also associated with

Rating

Cationic lipids and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cationic lipids and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cationic lipids and methods of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4177513